Medical Directors receive USYD VC’s Award
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.
The 'Outstanding Research Award' recognises their life-saving discoveries transforming melanoma patient care.
The award recognises her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Drug therapy looks set to become the standard treatment for high-risk early stage melanoma patients.
“The future looks bright – I truly believe that we will get to zero deaths from melanoma with the trajectory we’re following.”
Successful trial of a new immunotherapy drug which offers a third, and less toxic, option for the treatment of advanced melanoma.
MIA Co-Medical Director, Professor Georgina Long, who has been recognised in the 2020 Queen’s Birthday Honours List.
MIA's world leading researchers receive NHMRC grants to further their melanoma research, taking us closer to reaching zero deaths from melanoma.